Pemphigus Vulgaris: Present and Future Therapeutic Strategies

Pemphigus Vulgaris: Present and Future Therapeutic Strategies

Pemphigus vulgaris (PV) belongs to the group of autoimmune blistering diseases. PV can affect not only mucous membranes, but also the skin and it is characterized by serum IgG autoantibodies against desmoglein 1 and 3, two major components of desmosomes. The introduction of glucocorticoids improved...

Full description

Bibliographic Details
Main Authors: Dario Didona, Giovanni Paolino, Giovanni Di Zenzo, Biagio Didona, Riccardo Pampena, Matteo Riccardo Di Nicola, Santo Raffaele Mercuri
Format: Article
Language:English
Published: Mattioli1885 2022-02-01
Series:Dermatology Practical & Conceptual
Subjects:
anti-CD20 antibodies
neonatal Fc receptor (FcRn)
pemphigus
rituximab
treatment
Online Access:http://www.dpcj.org/index.php/dpc/article/view/1867

Internet

http://www.dpcj.org/index.php/dpc/article/view/1867

Similar Items